Full article view2018-09-26T10:56:18+00:00

Precision Xtract Covers Economic Assessment of Novel Gene and Cellular Therapies in the Journal of Clinical Pathways

 

Phil Cyr and Larry Blandford offer their experience and insights on developing health economic models for gene and cellular therapies. 

To read the full article, click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

What kind of expertise do you need?





By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK